Phase II trial of oral gimatecan in adults with recurrent glioblastoma

被引：0

作者：

Hu, J. ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

Wen, P. Y. ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

Abrey, L. E. ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

Fadul, C. ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

Drappatz, J. ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

Salem, N. ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

Amato, A. ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

Carminati, P. ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

Supko, J. ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

Hochberg, F. ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

机构：

[1] Massachusetts Gen Hosp, Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02114 USA

[2] Brigham & Womens Canc Ctr, Dana Farber Canc Inst, Boston, MA USA

[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[4] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA

[5] Sigma Tau Res Inc, Gaithersburg, MD USA

[6] Sigma Tau Ind Farmaceut Reiunite SpA, Pomezia, Italy

[7] Harvard Univ, Ctr Canc, Dana Farber Canc Inst, Boston, MA 02115 USA

[8] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2009

引用

页数：2

共 50 条

[1] A phase II trial of oral gimatecan for recurrent glioblastoma
Jethro Hu
Patrick Y. Wen
Lauren E. Abrey
Camilo E. Fadul
Jan Drappatz
Nadia Salem
Jeffrey G. Supko
Fred Hochberg
Journal of Neuro-Oncology, 2013, 111 : 347 - 353
[2] A phase II trial of oral gimatecan for recurrent glioblastoma
Hu, Jethro
Wen, Patrick Y.
Abrey, Lauren E.
Fadul, Camilo E.
Drappatz, Jan
Salem, Nadia
Supko, Jeffrey G.
Hochberg, Fred
JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (03) : 347 - 353
[3] Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme
Puduvalli, Vinay K.
Giglio, Pierre
Groves, Morris D.
Hess, Kenneth R.
Gilbert, Mark R.
Mahankali, Srikanth
Jackson, Edward F.
Levin, Victor A.
Conrad, Charles A.
Hsu, Sigmund H.
Colman, Howard
de Groot, John F.
Ritterhouse, MeLesa G.
Ictech, Sandra E.
Yung, W. K. Alfred
NEURO-ONCOLOGY, 2008, 10 (02) : 216 - 222
[4] Phase II trial of thalidomide in combination with irinotecan in adults with recurrent glioblastoma multiforme
Puduvalli, VK
Giglio, P
Groves, MD
Hess, KR
Jackson, E
Mahankali, S
Gilbert, M
Levin, VA
Conrad, C
Hsu, S
Yung, WKA
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 120S - 120S
[5] Phase II trial of gefitinib in recurrent glioblastoma
Rich, JN
Reardon, DA
Peery, T
Dowell, JM
Quinn, JA
Penne, KL
Wikstrand, CJ
Van Duyn, LB
Dancey, JE
McLendon, RE
Kao, JC
Stenzel, TT
Rasheed, BKA
Tourt-Uhlig, SE
Herndon, JE
Vredenburgh, JJ
Sampson, JH
Friedman, AH
Bigner, DD
Friedman, HS
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) : 133 - 142
[6] Phase I trial and pharmacokinetic study of oral gimatecan in adults with malignant glioma.
Hochberg, E. H.
Supko, J.
Amato, A.
Salem, N.
Carminati, P.
Wen, P.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 72S - 72S
[7] PHASE II TRIAL OF ENZASTAURIN (ENZ) WITH BEVACIZUMAB (BV) IN ADULTS WITH RECURRENT GLIOBLASTOMA (GEM)
Moustakas, Argirios
Iwamoto, Fabio M.
Kreisl, Teri N.
Sul, Joohee
Kim, Lyndon
Butman, John
Albert, Paul
Fine, Howard A.
NEURO-ONCOLOGY, 2010, 12 : 37 - 37
[8] Phase II trial of dovitinib in recurrent glioblastoma.
Ahluwalia, Manmeet Singh
Papadantonakis, Nikolaos
Venur, Vyshak Alva
Schilero, Cathy
Peereboom, David M.
Stevens, Glen
Rosenfeld, Steven
Vogelbaum, Michael A.
Elson, Paul
Nixon, Andrew B.
McCrae, Keith
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[9] Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma
Kunwar, Sandeep
Chang, Susan
Westphal, Manfred
Vogelbaum, Michael
Sampson, John
Barnett, Gene
Shaffrey, Mark
Ram, Zvi
Piepmeier, Joseph
Prados, Michael
Croteau, David
Pedain, Christoph
Leland, Pamela
Husain, Syed R.
Joshi, Bharat H.
Puri, Raj K.
NEURO-ONCOLOGY, 2010, 12 (08) : 871 - 881
[10] A PHASE II TRIAL OF SUNITINIB IN THE TREATMENT OF RECURRENT GLIOBLASTOMA (GBM)
Kreisl, Teri N.
Smith, P.
Iwamoto, Fabio
Sul, Joohee
Butman, John A.
Fine, Howard A.
NEURO-ONCOLOGY, 2010, 12 : 71 - 72

← 1 2 3 4 5 →